Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-25 6:41 pm Sale | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 2,346,630 4.44% | -800,000 (-25.42%) | View |
| 2024-02-09 8:14 pm Sale | 13G | EFFECTOR THERAPEUTICS INC EFTR | SR ONE CAPITAL MANAGEMENT LLC | 0 0% | -6,822,114 (Position Closed) | View |
| 2023-12-18 4:16 pm Sale | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 3,146,630 6.46% | -800,000 (-20.27%) | View |
| 2023-06-02 4:46 pm Sale | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 3,946,630 8.22% | -540,544 (-12.05%) | View |
| 2023-05-19 5:02 pm Sale | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 4,487,174 9.35% | -1,012,833 (-18.42%) | View |
| 2022-06-27 4:35 pm Unchanged | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 5,500,007 12.9% | 0 (Unchanged) | View |
| 2022-02-17 12:46 pm Purchase | 13D | ARCELLX INC ACLX | SR ONE CAPITAL MANAGEMENT LLC | 5,500,007 15.8% | 5,500,007 (New Position) | View |
| 2022-02-11 8:35 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | SR ONE CAPITAL MANAGEMENT LLC | 6,822,114 16.9% | 6,822,114 (New Position) | View |